NeuropaCalm
  • HOME
  • PATIENTS
  • ANSWERS
  • ABOUT US
  • NEWS
  • CONTACT
  • LOG IN |>>

Press Release: NeuropaCalm Launches a New User-Friendly and Comprehensive Website

1/10/2023

0 Comments

 
Picture
RENO, NV, UNITED STATES, January 10, 2023 – NeuropaCalm, a pioneer in the effective management of peripheral neuropathy symptoms, proudly announces the launch of its newly redesigned website.

A Newly Redesigned Website
The new website showcases a streamlined and contemporary design, better functionality, and user-friendly access to essential information, including assessments, videos, and more. These improvements will ensure that our members in the pharmacy and convenient care clinic industries are no more than a few clicks away from the resources and materials needed to educate their patients about neuropathy and the NeuropaCalm Care Program. 

Convenient care clinics and independent pharmacies offering the NeuropaCalm Care Program provide their customers with the highest level of care. They need regular access to the most up-to-date health information possible. Our new website design puts the latest research, findings, and resources at your fingertips. All in one convenient location. Think of it as your facility’s one-stop shop for marketing, educational, and professional development needs. 
​
The neuropacalm care program
“We are pleased to introduce our new company website to our clients and their employees. The NeuropaCalm Care Program provides symptomatic relief and restored quality of life to patients and caregivers, permitting clinics and pharmacies to reach untapped, though readily available, markets,” explains Patrick Doyle, NeuropaCalm’s founder and CEO. “Our updated website will provide members with an optimized experience, placing a comprehensive offering of educational resources and marketing materials at their fingertips. We take the guesswork out of selling the NeuropaCalm Care Program.” 

NeuropaCalm’s website will be updated regularly with information about our products, vital member resources, regulatory changes, and news relevant to your business. We encourage you to explore the website and sign up for membership to gain access to our full library of resources and the NeuropaCalm Care Program. 

Or, for more information about our comprehensive, affordable NeuropaCalm Care Program, schedule a virtual appointment. 

About Patrick Doyle 
Patrick Doyle is the founder of NeuropaCalm and Neurolight Treatment and a pioneer of the infrared medical device industry since 2003. In 2008, he entered the neuropathy care space exclusively and, in 2017, established a dedicated peripheral neuropathy clinic. Previous work with AT&T Structured Cabling Systems inspired the introduction of the “programs versus parts” concept, which distinguishes NeuropaCalm. He’s sold devices to 300+ clinics nationwide and now makes care kits available to pharmacies/convenient care clinics to ensure patients benefit from highly affordable and effective care options.

0 Comments

    ARTICLES

    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    August 2024
    July 2024
    May 2024
    April 2024
    March 2024
    January 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022

    RSS Feed

Picture
Manufactured in FDA registered US facility conforming to GMP & CRF800.
TEL: (775) 382-1415
HOURS: 8:00 am - 4:00 pm PST (Mon-Fri)
EMAIL: [email protected]
ADDRESS: 7750 W 4th St Unit 122  Reno NV 89523
Picture
NeuropaCalm® name and logo are registered trademarks. © 2024 NeuropaCalm
​ALL RIGHT RESERVED
​PRIVACY POLICY
REPAIRS

    Subscribe to our newsletter 

    Stay informed about diabetic peripheral neuropathy and the impactful work of medical professionals in this field.
Subscribe to Newsletter
 Site powered by Good Ink
  • HOME
  • PATIENTS
  • ANSWERS
  • ABOUT US
  • NEWS
  • CONTACT
  • LOG IN |>>